TRML(Delisted)
Tourmaline Bio·NASDAQ
--
--(--)
TRML fundamentals
During Q2 2025, Tourmaline Bio (TRML) reported revenue of --, a YoY change of 0.00%. Net income was -23.09M, a YoY change of -32.05%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 4.97M -- | 4.74M -- | 6.14M -- | 6.83M -- | 9.01M +81.04% | 11.06M +133.42% | 13.06M +112.72% | 14.39M +110.50% | 18.41M +104.49% | 18.41M +66.55% | 19.82M +51.82% | -36.95M -356.82% | 7.50M -59.26% | 16.37M -11.08% | 6.64M -66.49% | 14.89M +140.30% | 17.52M +133.50% | 21.97M +34.18% | 24.44M +267.88% | 25.81M +73.31% | 26.23M +49.75% | 25.97M +18.22% | 102.45M -- |
Selling, General and Administrative Expenses | 1.44M -- | 1.33M -- | 2.18M -- | 2.45M -- | 2.54M +76.30% | 3.49M +161.20% | 3.87M +77.54% | 3.80M +54.83% | 4.22M +66.26% | 5.23M +49.93% | 4.84M +24.99% | -12.11M -418.93% | 1.36M -67.64% | 1.92M -63.27% | 2.88M -40.50% | 6.88M +156.76% | 6.14M +349.89% | 6.24M +224.84% | 5.11M +77.30% | 5.26M -23.48% | 5.97M -2.74% | 6.34M +1.65% | 22.68M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 7.41M -- | -- -- | -- -- | -- -- | 13.26M +79.07% | -- -- | -- -- | -- -- | 2.17M -83.60% | -- -- | 1.92M -- | 2.88M -- | 6.88M +216.09% | 6.14M -- | 6.24M +224.84% | 5.11M +77.30% | 5.26M -23.48% | 5.97M -2.74% | 6.34M +1.65% | 22.68M -- |
Research and Development Expenses | 3.54M -- | 3.40M -- | 3.96M -- | 4.38M -- | 6.47M +82.97% | 7.57M +122.52% | 9.18M +132.13% | 10.59M +141.67% | 14.20M +119.48% | 13.19M +74.20% | 14.98M +63.14% | -24.84M -334.54% | 6.14M -56.77% | 14.45M +9.61% | 3.76M -74.89% | 8.02M +132.27% | 11.38M +85.37% | 15.73M +8.86% | 19.33M +413.82% | 20.55M +156.33% | 20.26M +78.08% | 19.63M +24.79% | 79.77M -- |
Operating Income | -4.97M -- | -4.74M -- | -6.14M -- | -6.83M -- | -9.01M -81.04% | -11.06M -133.42% | -13.06M -112.72% | -14.39M -110.50% | -18.41M -104.49% | -18.41M -66.55% | -19.82M -51.82% | 36.95M +356.82% | -7.50M +59.26% | -16.37M +11.08% | -6.64M +66.49% | -14.89M -140.30% | -17.52M -133.50% | -21.97M -34.18% | -24.44M -267.88% | -25.81M -73.31% | -26.23M -49.75% | -25.97M -18.22% | -102.45M -- |
Non-Operating Income (Loss) | 126.00K -- | 74.00K -- | -279.00K -- | 56.00K -- | -294.00K -333.33% | -295.00K -498.65% | 116.00K +141.58% | 147.00K +162.50% | 155.00K +152.72% | 319.00K +208.14% | 812.00K +600.00% | -1.29M -974.83% | 0 -100.00% | 245.00K -23.20% | 1.05M +29.56% | 1.99M +254.59% | 4.21M -- | 4.48M +1730.20% | 4.26M +305.04% | 3.57M +79.63% | 3.26M -22.47% | 2.88M -35.73% | 13.97M -- |
Other Non-Operating Income (Loss) | 126.00K -- | 74.00K -- | -279.00K -- | 79.00K -- | -294.00K -333.33% | -295.00K -498.65% | 116.00K +141.58% | 473.00K +498.73% | 155.00K +152.72% | 319.00K +208.14% | 812.00K +600.00% | -1.29M -371.88% | 0 -100.00% | 245.00K -23.20% | 1.05M +29.56% | 1.99M +254.59% | 4.21M -- | 4.48M +1730.20% | 4.26M +305.04% | 3.57M +79.63% | 3.26M -22.47% | 2.88M -35.73% | 13.97M -- |
Net Interest Expense | -- -- | -- -- | -- -- | 23.00K -- | -- -- | -- -- | -- -- | 326.00K +1317.39% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -4.85M -- | -4.66M -- | -6.42M -- | -6.78M -- | -9.30M -91.81% | -11.35M -143.45% | -12.94M -101.67% | -14.24M -110.08% | -18.26M -96.35% | -18.10M -59.41% | -19.01M -46.91% | 35.66M +350.44% | -7.50M +58.91% | -16.13M +10.87% | -5.59M +70.59% | -12.90M -136.18% | -13.31M -77.43% | -17.49M -8.42% | -20.18M -260.88% | -22.23M -72.34% | -22.97M -72.56% | -23.09M -32.05% | -88.47M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -4.85M -- | -4.66M -- | -6.42M -- | -6.78M -- | -9.30M -91.81% | -11.35M -143.45% | -12.94M -101.67% | -14.24M -110.08% | -18.26M -96.35% | -18.10M -59.41% | -19.01M -46.91% | 35.66M +350.44% | -7.50M +58.91% | -16.13M +10.87% | -5.59M +70.59% | -12.90M -136.18% | -13.31M -77.43% | -17.49M -8.42% | -20.18M -260.88% | -22.23M -72.34% | -22.97M -72.56% | -23.09M -32.05% | -88.47M -- |
Net Income Attributable to Owners of the Company | -4.85M -- | -4.66M -- | -6.42M -- | -6.78M -- | -9.30M -91.81% | -11.35M -143.45% | -12.94M -101.67% | -14.24M -110.08% | -18.26M -96.35% | -18.10M -59.41% | -19.01M -46.91% | 35.66M +350.44% | -7.50M +58.91% | -16.13M +10.87% | -5.59M +70.59% | -12.90M -136.18% | -13.31M -77.43% | -17.49M -8.42% | -20.18M -260.88% | -22.23M -72.34% | -22.97M -72.56% | -23.09M -32.05% | -88.47M -- |
Net Income Attributable to Common Stockholders | -4.85M -- | -4.66M -- | -6.42M -- | -6.78M -- | -9.30M -91.81% | -11.35M -143.45% | -12.94M -101.67% | -14.24M -110.08% | -18.26M -96.35% | -18.10M -59.41% | -19.01M -46.91% | 35.66M +350.44% | -7.50M +58.91% | -16.13M +10.87% | -5.59M +70.59% | -12.90M -136.18% | -13.31M -77.43% | -17.49M -8.42% | -20.18M -260.88% | -22.23M -72.34% | -22.97M -72.56% | -23.09M -32.05% | -88.47M -- |
Other Comprehensive Income | 13.00K -- | 7.00K -- | -12.00K -- | -21.00K -- | 22.00K +69.23% | 25.00K +257.14% | -5.00K +58.33% | -107.00K -409.52% | -848.00K -3954.55% | -217.00K -968.00% | -79.00K -1480.00% | 1.14M +1169.16% | 0 +100.00% | -- -- | -- -- | 67.00K -94.14% | -320.00K -- | -199.00K -- | 1.27M -- | -525.00K -883.58% | -69.00K +78.44% | -106.00K +46.73% | 573.00K -- |
Total Comprehensive Income | -4.83M -- | -4.66M -- | -6.43M -- | -6.80M -- | -9.28M -91.87% | -11.33M -143.28% | -12.95M -101.37% | -14.35M -111.00% | -19.11M -105.96% | -18.31M -61.68% | -19.09M -47.46% | 36.81M +356.54% | -7.50M +60.74% | -16.13M +11.93% | -5.59M +70.71% | -12.84M -134.87% | -13.63M -81.70% | -17.69M -9.65% | -18.90M -238.11% | -22.76M -77.33% | -23.04M -69.02% | -23.20M -31.17% | -87.90M -- |
Total Comprehensive Income Attributable to Owners of the Company | -4.83M -- | -4.66M -- | -6.43M -- | -6.80M -- | -9.28M -91.87% | -11.33M -143.28% | -12.95M -101.37% | -14.35M -111.00% | -19.11M -105.96% | -18.31M -61.68% | -19.09M -47.46% | 36.81M +356.54% | -7.50M +60.74% | -16.13M +11.93% | -5.59M +70.71% | -12.84M -134.87% | -13.63M -81.70% | -17.69M -9.65% | -18.90M -238.11% | -22.76M -77.33% | -23.04M -69.02% | -23.20M -31.17% | -87.90M -- |
Basic EPS | -0.76 -- | -0.73 -- | -0.94 -- | -- -- | -1.3 -71.05% | -0.41 +43.84% | -0.32 +65.96% | -0.35 -- | -0.45 +65.38% | -0.44 -7.32% | -4.59 -1334.37% | 0.86 +345.71% | -8.28 -1740.00% | -16.29 -3602.27% | -5.16 -12.42% | -0.63 -173.26% | -0.55 +93.36% | -0.68 +95.83% | -0.78 +84.88% | -0.87 -38.10% | -0.89 -61.82% | -0.9 -32.35% | -3.44 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -16.29 -- | -5.16 -- | -- -- | -0.55 -- | -0.68 +95.83% | -0.78 +84.88% | -- -- | -0.89 -61.82% | -0.9 -32.35% | -- -- |
Diluted EPS | -0.76 -- | -0.73 -- | -0.94 -- | -- -- | -1.3 -71.05% | -0.41 +43.84% | -0.32 +65.96% | -- -- | -0.45 +65.38% | -0.44 -7.32% | -4.59 -1334.37% | -- -- | -8.28 -1740.00% | -16.29 -3602.27% | -5.16 -12.42% | -- -- | -0.55 +93.36% | -0.68 +95.83% | -0.78 +84.88% | -- -- | -0.89 -61.82% | -0.9 -32.35% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -16.29 -- | -5.16 -- | -- -- | -0.55 -- | -0.68 +95.83% | -0.78 +84.88% | -- -- | -0.89 -61.82% | -0.9 -32.35% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
